cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2007; 50:808-817, doi:10.1016/j.jacc.2007.04.069 (Published online 6 August 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.04.069v1
50/8/808    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, X.
Right arrow Articles by Janssens, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Liu, X.
Right arrow Articles by Janssens, S.

PRECLINICAL STUDY

Nitric Oxide Inhalation Improves Microvascular Flow and Decreases Infarction Size After Myocardial Ischemia and Reperfusion

Xiaoshun Liu, MD, PhD*, Yanming Huang, MD, PhD*, Peter Pokreisz, PhD{dagger}, Pieter Vermeersch, MD{dagger}, Glenn Marsboom, MSc{dagger}, Marc Swinnen*, Eric Verbeken, MD, PhD{ddagger}, Jose Santos, MD*, Marijke Pellens{dagger}, Hilde Gillijns{dagger}, Frans Van de Werf, MD, PhD*, Kenneth D. Bloch, MD§,2 and Stefan Janssens, MD, PhD*,{dagger},1,2,*

* Department of Cardiology, University of Leuven, Leuven, Belgium
{dagger} Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute of Biotechnology, University of Leuven, Leuven, Belgium
{ddagger} Department of Pathology, University of Leuven, Leuven, Belgium
§ Cardiovascular Research Center, Department of Medicine, and Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Manuscript received October 3, 2006; revised manuscript received April 2, 2007, accepted April 10, 2007.

* Reprint requests and correspondence: Dr. Stefan Janssens, Department of Cardiology and Center for Transgene Technology and Gene Therapy, University of Leuven, Belgium. (Email: stefan.janssens{at}uz.kuleuven.ac.be).

Objectives: The purpose of this study was to test if nitric oxide (NO) could improve microvascular perfusion and decrease tissue injury in a porcine model of myocardial ischemia and reperfusion (I/R).

Background: Inhaled NO is a selective pulmonary vasodilator with biologic effects in remote vascular beds.

Methods: In 37 pigs, the midportion of the left anterior descending coronary artery was occluded for 50 min followed by 4 h of reperfusion. Pigs were treated with a saline infusion (control; n = 14), intravenous nitroglycerin (IV-NTG) at 2 µg/kg/min (n = 11), or inhaled nitric oxide (iNO) at 80 parts per million (n = 12) beginning 10 min before balloon deflation and continuing throughout reperfusion.

Results: Total myocardial oxidized NO species in the infarct core was greater in the iNO pigs than in the control or IV-NTG pigs (0.60 ± 0.05 nmol/mg tissue vs. 0.40 ± 0.03 nmol/mg tissue and 0.40 ± 0.02 nmol/mg tissue, respectively; p < 0.01 for both). Infarct size, expressed as percentage of left ventricle area at risk (AAR), was smaller in the iNO pigs than in the control or IV-NTG pigs (31 ± 6% AAR vs. 58 ± 7% AAR and 46 ± 7% AAR, respectively; p < 0.05 for both) and was associated with less creatine phosphokinase-MB release. Inhaled NO improved endocardial and epicardial blood flow in the infarct zone, as measured using colored microspheres (p < 0.001 vs. control and IV-NTG). Moreover, NO inhalation reduced leukocyte infiltration, as reflected by decreased cardiac myeloperoxidase activity (0.8 ± 0.2 U/mg tissue vs. 2.3 ± 0.8 U/mg tissue in control and 1.4 ± 0.4 U/mg tissue in IV-NTG; p < 0.05 for both) and decreased cardiomyocyte apoptosis in the infarct border zone.

Conclusions: Inhalation of NO just before and during coronary reperfusion significantly improves microvascular perfusion, reduces infarct size, and may offer an attractive and novel treatment of myocardial infarction.

Abbreviations and Acronyms
  AAR = area at risk
  iNO = inhaled nitric oxide
  LV = left ventricle/ventricular
  MPO = myeloperoxidase
  MVO = microvascular obstruction
  NO = nitric oxide
  NOx = oxidized nitric oxide species
  NTG = nitroglycerin




This article has been cited by other articles:


Home page
CirculationHome page
F. M. Gonzalez, S. Shiva, P. S. Vincent, L. A. Ringwood, L.-Y. Hsu, Y. Y. Hon, A. H. Aletras, R. O. Cannon III, M. T. Gladwin, and A. E. Arai
Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction
Circulation, June 10, 2008; 117(23): 2986 - 2994.
[Abstract] [Full Text] [PDF]



 
  cardiology careers collections past issues search home